Explore program updates - including upcoming datas and deadlines ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­    ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­  
View in browser
IHA-logo-primary-320w

AMP-logo-no-endorsement-180w

AUGUST 2026

AMP Monthly Newsletter

newsletter-banner-photo-01

 

quick links

AMP Technical FAQ

Questions and Appeals Period Resources

Newsletter archive

 

need to do

Coming soon: Preliminary MY 2025 Performance Results

 

On August 20, the Preliminary MY 2025 AMP Performance Results will be available for all AMP participants. These preliminary results include clinical quality results submitted through FinThrive and will be accessible through the same location where you access your AMP Pulse reports. This interactive, visual report will include self- reported, plan-specific, and aggregated rates, clear year-over-year changes, and comparison to national benchmarks.

 

AMP participants will receive an email from notify@mail.hex.tech when the results are ready. Results can also be accessed through the IHA website. To view results, users will need to login using their work email address.

Don’t forget to register for the Preliminary MY 2025 Performance Results Webinar 

 

Join us Thursday, August 20, for an overview of the Preliminary MY 2025 AMP Performance Results. We’ll dive into program updates, preliminary performance insights, and how to access your results. We will also cover what to do if you have questions or appeals. If you aren’t able to attend, the session will be recorded and made available on our website.

 

Preliminary MY 2025 Performance Results Webinar 

Thursday, August 20 | 1:00 pm – 2:30 pm PT

Register Now

Questions and Appeals Period for Preliminary MY 2025 Performance Results 

 

The AMP MY 2025 Questions and Appeals Period opens on August 20. This is your opportunity to review your results, check for possible errors, and submit any questions or appeals related to results submitted through FinThrive. The Questions and Appeals Period ends on September 16. To give IHA and our partners adequate time to fully investigate each submission, we strongly encourage you to submit as early as possible.

 

Resources on how to review your AMP data and submit a question or appeal will be available on the IHA website by this Friday, August 14.

 

How to submit a question or appeal:

  1. Review the AMP Questions and Appeals Submission Guide, Roles and Responsibilities, Best Practices, and FAQs (available on the Data collection, submission, and audit resources webpage).

  2. Identify the provider organization name and AMP PO ID, measure rates in question and applicable product lines and health plans, and any rationale and documentation to substantiate the claim. Do not submit any PHI.

  3. Email the identified information using our Submission Form to appeals@iha.org by Wednesday, September 16, 5 p.m. PT. Use the following as the subject line:

    Subject: Question (or Appeal) - Your Organization Name (AMP PO ID, if applicable) - Short Description of Issue  

Important activities and dates:

  • August 20: Preliminary MY 2025 Performance Results released to participants and Preliminary MY 2025 Performance Results Webinar

  • August 20 – September 16: Questions and Appeals submission period for FinThrive pipeline

  • September 23: Health plans must generate results for their auditor to review for any necessary FinThrive resubmissions

  • September 30: FinThrive must receive auditor-locked resubmissions due to the Questions and Appeals Period, and these files must be in validation pass

  • September 30: Last day to finalize any communications and documentation related to Questions and Appeals

  • October 2: Appeals hearing

  • October 9: Appeals decisions communicated to participants

  • November 16: Final MY 2025 Performance Results released to participants

Health Plans: refer to the AMP Technical FAQ for updated MY 2025 timelines

 

Since the release of the Final AMP MY 2025 Program Guide on December 15, 2025, several AMP program deadlines and milestone dates have been updated to support the transition to Cozeva, including Cozeva's efforts to bring all AMP-related operations onshore in the United States. To provide a centralized source for the most current information, beyond updates shared through webinars and other program communications, IHA has updated the AMP Technical FAQ with the latest MY 2025 timelines.

 

Health plans should refer to the AMP Technical FAQ for the most up-to-date dates and deadlines related to MY 2025 AMP Performance Results release, Questions & Appeals, and upcoming data submissions to Cozeva. The timelines published in the FAQ supersede those included in the AMP MY 2025 Program Guide.

Health Plans: Cozeva Data Quality Report review

 

As previously communicated during the July 30 AMP Technical Data Intake meeting and the June 25 Health Plan Quarterly meeting, IHA and Cozeva are focusing on data quality review throughout the remainder of 2026 to ensure high-quality results during this transition year. Enhanced Data Quality Reports are being distributed to health plans via email based on data submitted to-date across all file types. IHA and Cozeva will highlight key data quality findings to help guide your review and investigation efforts. We will partner with you to address identified issues and complete any necessary corrections or resubmissions.

 

Below are the expected dates for when health plans will receive Enhanced Data Quality Reports and when issues must be resolved:

  • Late July – September 15: Enhanced Data Quality Report review period for all file types.
  • September 15: Enhanced Data Quality Report resubmission deadline.
  • September 15 – October 15: Validate Enhanced Data Quality Report resubmissions and complete any necessary corrections to prepare for data lock on October 15.

 

in other news

Now available: AMP PO Stars Report — MY 2024 results

 

The AMP PO Stars Report has been updated with MY 2024 results and is now available to all participating AMP provider organizations. This interactive report provides a centralized, dynamic view of your clinical quality and total cost of care performance, mapped to your Office of the Patient Advocate (OPA) star ratings. With drill-down features and peer comparisons against 200+ California provider organizations, you can quickly identify where your organization is performing well and where the greatest opportunities for improvement may be. To get started, use the self-directed interactive tutorial for step-by-step guidance on accessing and using your report. 

Access your report

NCQA’s ad hoc HEDIS® Public Comment Period ends August 17

 

NCQA is currently seeking feedback about the proposed retirement of select HEDIS® measures in Measurement Year (MY) 2027. These proposed changes are intended to strengthen the HEDIS portfolio by identifying measures that may no longer provide strong signals for quality improvement, benchmarking, or accountability relative to the burden of continued reporting and maintenance. To review the proposed changes and submit comments, please visit NCQA.org.

 

in the pipeline

Health Plans: MY 2027 Data Submission Guide 11.0 release

 

The final MY 2027 Data Submission Guide (DSG) 11.0 will be published on the IHA website on August 31, 2026 on the AMP Core Data Collection, Submission, and Audit Resources page. The DSG outlines the MY 2027 AMP reporting requirements and submission specifications for data submitted to Cozeva.

 

The final version incorporates feedback received during the health plan review period, along with changes approved by the Program Governance Committee. Health plans should review DSG 11.0 and begin planning for implementation of any updated requirements.

 

The first data submission using DSG 11.0 will be due to Cozeva on February 28, 2027. 

Never miss an update

Did someone share this email with you? Receive IHA news and program updates in your inbox by signing up for our newsletter.
Sign Up

Integrated Healthcare Association, 180 Grand Avenue, Suite 1365, Oakland, CA 94612

Unsubscribe Manage preferences